Key facts
- Notable investors include Chengdu High-Tech Investment, Orinno Capital, Chengdu New Economy Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Mediverse (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for Mediverse (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mediverse (China)
Manufacturer of personalised surgical implants and guides intended to support precise and patient-specific surgical intervention. The company offers AI-based imaging integration, intelligent surgical planning, and in-house additive manufacturing, enabling hospitals and surgical teams to achieve higher procedural accuracy and improved clinical consistency.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Mediverse (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mediverse (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mediverse (China) in its N-PORT filings yet. We sweep new filings monthly.